DETERMINATION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND ITS METABOLITES IN BIOMEDICAL SPECIMENS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYKONO A; TANAKA M; EGUCHI S et al.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 163; NO 1; PP. 109-113; BIBL. 4 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AFTER ORAL ADMINISTRATION IN MICEIIGO M; NAKAMURA A; KURETANI K et al.1980; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1980; VOL. 10; NO 11; PP. 847-854; BIBL. 8 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL IN MICE BEARING ASCITES SARCOMA 180IIGO M; KURETANI K; HOSHI A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 345-349; BIBL. 13 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN RATSKOBARI T; TAN K; KUMAKURA M et al.1978; XENOBIOTICA; GBR; DA. 1978; VOL. 8; NO 9; PP. 547-556; BIBL. 17 REF.Article

METABOLISM OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL (HCFU): A NEW ANTITUMOUR AGENT, IN RATS, RABBITS AND DOGSKOBARI T; IGURO Y; UJIIE A et al.1981; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1981; VOL. 11; NO 1; PP. 57-62; BIBL. 6 REF.Article

Hyperthermia enhances the in vitro activity of 1-hexylcarbamoyl-5-fluorouracil compared to that of 5-fluorouracilKUSUMOTO, T; MAEHARA, Y; SAKAGUCHI, Y et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 3, pp 477-481, issn 0277-5379Article

Selective transfer of 1-hexylcarbamoyl-5-fluorouracil into lymphatics by combination of β-cyclodextrin polymer complexation and absorption promoter in the ratKAJI, Y; UEKAMA, K; YOSHIKAWA, H et al.International journal of pharmaceutics. 1985, Vol 24, Num 1, pp 79-89, issn 0378-5173Article

EFFECT OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL ON SPONTANEOUS MAMMARY ADENOCARCINOMA OF MICETOKUZEN R; IIGO M; HOSHI A et al.1980; GANN; ISSN 0016-450X; JPN; DA. 1980; VOL. 71; NO 5; PP. 724-728; BIBL. 11 REF.Article

CHEMOTHERAPEUTIC STUDY ON CANINE GASTRIC CANCER INDUCED BY N-ETHYL-N'-NITROSO-N-NITROSOGUANIDINEMATSUKURA N; AOYAGI M; KAWACHI T et al.1980; GANN; ISSN 0016-450X; JPN; DA. 1980; VOL. 71; NO 3; PP. 349-355; BIBL. 13 REF.Article

INHIBITION OF MURINE COLON ADENOCARCINOMAS AND LEWIS LUNG CARCINOMA BY 1-HEXYLCARBAMOYL-5-FLUOROURACILTSURUO T; IIDA H; NAGANUMA K et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 2; PP. 83-87; BIBL. 14 REF.Article

EXCRETION OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN URINE OF MICEIIGO M; NAKAMURA A; KURETANI K et al.1981; J. PHARMACOBIO-DYN; ISSN 0386-846X; JPN; DA. 1981; VOL. 4; NO 7; PP. 490-496; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL IN A VARIETY OF EXPERIMENTAL TUMORS.HOSHI A; IIGO M; NAKAMURA A et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 5; PP. 725-731; BIBL. 15 REF.Article

The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assayNISHIYAMA, M; TAKAGAMI, S; KIRIHARA, Y et al.Japanese journal of surgery. 1988, Vol 18, Num 6, pp 725-728, issn 0047-1909Article

1-Hexylcarbamoyl-5-fluorouracil is more cytostatic than 5-fluorouracil against human tumors in vitroMAEHARA, Y; KUSUMOTO, H; ANAI, H et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 10, pp 1511-1515, issn 0277-5379Article

Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitroTSUMURA, M; YOSHIGA, K; TAKADA, K et al.Cancer research (Baltimore). 1988, Vol 48, Num 14, pp 3977-3980, issn 0008-5472Article

Effect of 1-hexylcarbamoyl-5-fluorouracil on development of rat urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamineOZONO, S; IWATA, H; TSUNEMI, K et al.Japanese journal of experimental medicine. 1988, Vol 58, Num 3, pp 123-127, issn 0021-5031Article

UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-flurouracil and 1-hexylcarbamoyl-5-fluorouracilMAEHARA, Y; KUSUMOTO, T; KUSUMOTO, H et al.Chemotherapy (Basel). 1988, Vol 34, Num 6, pp 484-489, issn 0009-3157Article